AmerisourceBergen

Drug Retailers

ABC

$ 149 (1.3)%

Share price

$ 31 bn

Market Cap

$ 38 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.1x the weighted average for S&P 500

FY2020

Primary Climate Goal

Proj. YOY change in GHG emissions (Scope 1 + 2)

FY2021

AmerisourceBergen aims to reduce Scope 1 + 2 by 5% by 2022 from a base year 2019

This target is most likely outdated and the company appears to have already achieved it

This target has not been verified as science based according to SBTi

GHG emissions and Carbon intensity

AmerisourceBergen reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 September 2020 at 108 Kt (-13 /-10.5% y-o-y). Also positively, carbon intensity plummeted to 0.6 t (-0.1 /-14.3% y-o-y).

AmerisourceBergen's Scope 3 emissions was down at 26 Kt (-2.6 /-9.1% y-o-y).

The company is committed to reducing Scope 1 + 2 by 5% by 2022 from a base year 2019, which it appears to have already achieved as of 2020. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Date	Total CO2e emissions (location-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2020Q3	108	33	74	26	189,894	0.6
2019Q3	120	34	87	28	179,589	0.7
2018Q3	128	37	90		167,940	0.8
2017Q3	123	38	86		153,144	0.8
2016Q3	118	33	85		146,850	0.8